Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Differential decay and prediction of persistence of Enterococcus spp. and Escherichia coli culturable cells and molecular markers in freshwater and seawater environments.

Sagarduy M, Courtois S, Del Campo A, Garmendia JM, Petrau A.

Int J Hyg Environ Health. 2019 May;222(4):695-704. doi: 10.1016/j.ijheh.2019.04.011. Epub 2019 May 13.

PMID:
31097324
2.

Faster and safer: Research priorities in water and health.

Setty K, Loret JF, Courtois S, Hammer CC, Hartemann P, Lafforgue M, Litrico X, Manasfi T, Medema G, Shaheen M, Tesson V, Bartram J.

Int J Hyg Environ Health. 2019 May;222(4):593-606. doi: 10.1016/j.ijheh.2019.03.003. Epub 2019 Mar 23.

PMID:
30910612
3.

The therapeutic potential of metformin in gastric cancer.

Courtois S, Lehours P, Bessède E.

Gastric Cancer. 2019 Jul;22(4):653-662. doi: 10.1007/s10120-019-00952-w. Epub 2019 Mar 21. Review.

PMID:
30900101
4.

Metformin can inhibit Helicobacter pylori growth.

Courtois S, Bénéjat L, Izotte J, Mégraud F, Varon C, Lehours P, Bessède E.

Future Microbiol. 2018 Nov;13:1575-1583. doi: 10.2217/fmb-2018-0184. Epub 2018 Nov 13.

PMID:
30421627
5.

Reduced Chlorine in Drinking Water Distribution Systems Impacts Bacterial Biodiversity in Biofilms.

Bertelli C, Courtois S, Rosikiewicz M, Piriou P, Aeby S, Robert S, Loret JF, Greub G.

Front Microbiol. 2018 Oct 23;9:2520. doi: 10.3389/fmicb.2018.02520. eCollection 2018.

6.

Microbial community analysis in biologically active filters exhibiting efficient removal of emerging contaminants and impact of operational conditions.

Zhang S, Courtois S, Gitungo S, Raczko RF, Dyksen JE, Li M, Axe L.

Sci Total Environ. 2018 Nov 1;640-641:1455-1464. doi: 10.1016/j.scitotenv.2018.06.027. Epub 2018 Jun 7.

PMID:
30021312
7.

Metformin targets gastric cancer stem cells.

Courtois S, Durán RV, Giraud J, Sifré E, Izotte J, Mégraud F, Lehours P, Varon C, Bessède E.

Eur J Cancer. 2017 Oct;84:193-201. doi: 10.1016/j.ejca.2017.07.020. Epub 2017 Aug 17.

PMID:
28822889
8.

New insights into the key microbial phylotypes of anaerobic sludge digesters under different operational conditions.

Hao L, Bize A, Conteau D, Chapleur O, Courtois S, Kroff P, Desmond-Le Quéméner E, Bouchez T, Mazéas L.

Water Res. 2016 Oct 1;102:158-169. doi: 10.1016/j.watres.2016.06.014. Epub 2016 Jun 6.

PMID:
27340817
9.

Delayed-onset Friedreich's ataxia revisited.

Lecocq C, Charles P, Azulay JP, Meissner W, Rai M, N'Guyen K, Péréon Y, Fabre N, Robin E, Courtois S, Guyant-Maréchal L, Zagnoli F, Rudolf G, Renaud M, Sévin-Allouet M, Lesne F, Alaerts N, Goizet C, Calvas P, Eusebio A, Guissart C, Derkinderen P, Tison F, Brice A, Koenig M, Pandolfo M, Tranchant C, Dürr A, Anheim M.

Mov Disord. 2016 Jan;31(1):62-9. doi: 10.1002/mds.26382. Epub 2015 Sep 21.

PMID:
26388117
10.

Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study.

Cohen M, Maillart E, Tourbah A, De Sèze J, Vukusic S, Brassat D, Anne O, Wiertlewski S, Camu W, Courtois S, Ruet A, Debouverie M, Le Page E, Casez O, Heinzlef O, Stankoff B, Bourre B, Castelnovo G, Rico A, Berger E, Camdessanche JP, Defer G, Clavelou P, Al Khedr A, Zephir H, Fromont A, Papeix C, Brochet B, Pelletier J, Lebrun C; Club Francophone de la Sclérose en Plaques Investigators.

JAMA Neurol. 2014 Apr;71(4):436-41. doi: 10.1001/jamaneurol.2013.6240.

PMID:
24566807
11.

Reduction of the washout time between natalizumab and fingolimod.

de Seze J, Ongagna JC, Collongues N, Zaenker C, Courtois S, Fleury M, Benoilid A, Chanson JB, Blanc F; Alsacep Network.

Mult Scler. 2013 Aug;19(9):1248. doi: 10.1177/1352458513490551. Epub 2013 May 30. No abstract available.

PMID:
23722322
12.

Rapid monitoring of Escherichia coli and Enterococcus spp. in bathing water using reverse transcription-quantitative PCR.

Bergeron P, Oujati H, Catalán Cuenca V, Huguet Mestre JM, Courtois S.

Int J Hyg Environ Health. 2011 Nov;214(6):478-84. doi: 10.1016/j.ijheh.2011.07.013. Epub 2011 Sep 13.

PMID:
21917514
13.

Persistence and dissemination of the multiple-antibiotic-resistance plasmid pB10 in the microbial communities of wastewater sludge microcosms.

Merlin C, Bonot S, Courtois S, Block JC.

Water Res. 2011 Apr;45(9):2897-905. doi: 10.1016/j.watres.2011.03.002. Epub 2011 Mar 10.

PMID:
21440282
14.

Improving the recovery of qPCR-grade DNA from sludge and sediment.

Bonot S, Courtois S, Block JC, Merlin C.

Appl Microbiol Biotechnol. 2010 Aug;87(6):2303-11. doi: 10.1007/s00253-010-2686-0. Epub 2010 Jun 19.

PMID:
20563719
15.

Z-osteotomy in hallux valgus: clinical and radiological outcome after Scarf osteotomy.

Jäger M, Schmidt M, Wild A, Bittersohl B, Courtois S, Schmidt TG, Rüdiger K.

Orthop Rev (Pavia). 2009 Jun 30;1(1):e4. doi: 10.4081/or.2009.e4.

16.

Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management.

Anheim M, Fleury M, Monga B, Laugel V, Chaigne D, Rodier G, Ginglinger E, Boulay C, Courtois S, Drouot N, Fritsch M, Delaunoy JP, Stoppa-Lyonnet D, Tranchant C, Koenig M.

Neurogenetics. 2010 Feb;11(1):1-12. doi: 10.1007/s10048-009-0196-y. Epub 2009 May 14.

PMID:
19440741
17.

Comparison of methods for concentrating human adenoviruses, polyomavirus JC and noroviruses in source waters and drinking water using quantitative PCR.

Albinana-Gimenez N, Clemente-Casares P, Calgua B, Huguet JM, Courtois S, Girones R.

J Virol Methods. 2009 Jun;158(1-2):104-9. doi: 10.1016/j.jviromet.2009.02.004. Epub 2009 Feb 12.

PMID:
19428577
18.

Nucleic acids as viability markers for bacteria detection using molecular tools.

Cenciarini-Borde C, Courtois S, La Scola B.

Future Microbiol. 2009 Feb;4(1):45-64. doi: 10.2217/17460913.4.1.45. Review.

PMID:
19207099
19.

Influence of long time storage in mineral water on RNA stability of Pseudomonas aeruginosa and Escherichia coli after heat inactivation.

Cenciarini C, Courtois S, Raoult D, La Scola B.

PLoS One. 2008;3(10):e3443. doi: 10.1371/journal.pone.0003443. Epub 2008 Oct 20.

20.

p53 protein variants: structural and functional similarities with p63 and p73 isoforms.

Courtois S, Caron de Fromentel C, Hainaut P.

Oncogene. 2004 Jan 22;23(3):631-8. Review.

PMID:
14737098
21.

[Progression of cerebral venous thromboses. A retrospective study].

Rodier G, Schlück E, Derouiche F, Bronner P, Boulay C, Courtois S, Cohen E.

Presse Med. 2003 May 10;32(16):728-33. French.

PMID:
12856530
22.

Recombinant environmental libraries provide access to microbial diversity for drug discovery from natural products.

Courtois S, Cappellano CM, Ball M, Francou FX, Normand P, Helynck G, Martinez A, Kolvek SJ, Hopke J, Osburne MS, August PR, Nalin R, Guérineau M, Jeannin P, Simonet P, Pernodet JL.

Appl Environ Microbiol. 2003 Jan;69(1):49-55.

23.

DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53.

Courtois S, Verhaegh G, North S, Luciani MG, Lassus P, Hibner U, Oren M, Hainaut P.

Oncogene. 2002 Oct 3;21(44):6722-8.

24.

[Thrombophilias associated with cerebral venous thrombosis].

Schlück E, Rodier G, Derouiche F, Bronner P, Boulay C, Courtois S, Cohen E.

Rev Neurol (Paris). 2002 May;158(5 Pt 1):543-52. Review. French.

PMID:
12072822
25.

The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene.

Duriez C, Falette N, Audoynaud C, Moyret-Lalle C, Bensaad K, Courtois S, Wang Q, Soussi T, Puisieux A.

Gene. 2002 Jan 9;282(1-2):207-14.

PMID:
11814693
26.

Quantification of bacterial subgroups in soil: comparison of DNA extracted directly from soil or from cells previously released by density gradient centrifugation.

Courtois S, Frostegård A, Göransson P, Depret G, Jeannin P, Simonet P.

Environ Microbiol. 2001 Jul;3(7):431-9.

PMID:
11553233
27.

[Lysosome enzyme pseudodeficiency].

Bronner P, Rodier G, Cohen E, Derouiche F, Boulay C, Courtois S.

Rev Neurol (Paris). 2000 Nov;156(11):1005-12. Review. French.

PMID:
11119053
28.

[Ciguatera and peripheral neuropathy: a case report].

Derouiche F, Cohen E, Rodier G, Boulay C, Courtois S.

Rev Neurol (Paris). 2000 May;156(5):514-6. French.

PMID:
10844372
29.

Comparison between different strategies of covalent attachment of DNA to glass surfaces to build DNA microarrays.

Zammatteo N, Jeanmart L, Hamels S, Courtois S, Louette P, Hevesi L, Remacle J.

Anal Biochem. 2000 Apr 10;280(1):143-50.

PMID:
10805532
30.

The flavonoid apigenin suppresses vitamin D receptor expression and vitamin D responsiveness in normal human keratinocytes.

Segaert S, Courtois S, Garmyn M, Degreef H, Bouillon R.

Biochem Biophys Res Commun. 2000 Feb 5;268(1):237-41.

PMID:
10652242
31.

Quantification of bias related to the extraction of DNA directly from soils.

Frostegård A, Courtois S, Ramisse V, Clerc S, Bernillon D, Le Gall F, Jeannin P, Nesme X, Simonet P.

Appl Environ Microbiol. 1999 Dec;65(12):5409-20.

32.

Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis.

Vantieghem A, Assefa Z, Vandenabeele P, Declercq W, Courtois S, Vandenheede JR, Merlevede W, de Witte P, Agostinis P.

FEBS Lett. 1998 Nov 27;440(1-2):19-24.

33.

Ultraviolet B suppresses vitamin D receptor gene expression in keratinocytes.

Courtois SJ, Segaert S, Degreef H, Bouillon R, Garmyn M.

Biochem Biophys Res Commun. 1998 May 8;246(1):64-9.

PMID:
9600069
34.

Low frequency of TSG101/CC2 gene alterations in invasive human breast cancers.

Wang Q, Driouch K, Courtois S, Champème MH, Bièche I, Treilleux I, Briffod M, Rimokh R, Magaud JP, Curmi P, Lidereau R, Puisieux A.

Oncogene. 1998 Feb 5;16(5):677-9.

35.

Early ultraviolet B-induced G1 arrest and suppression of the malignant phenotype by wild-type p53 in human squamous cell carcinoma cells.

Courtois SJ, Woodworth CD, Degreef H, Garmyn M.

Exp Cell Res. 1997 May 25;233(1):135-44.

PMID:
9184083
36.

p21(WAF1/CIP1) response to genotoxic agents in wild-type TP53 expressing breast primary tumours.

Guillot C, Falette N, Paperin MP, Courtois S, Gentil-Perret A, Treilleux I, Ozturk M, Puisieux A.

Oncogene. 1997 Jan 9;14(1):45-52.

37.

Alteration of p53 damage response by tamoxifen treatment.

Guillot C, Falette N, Courtois S, Voeltzel T, Garcia E, Ozturk M, Puisieux A.

Clin Cancer Res. 1996 Sep;2(9):1439-44.

38.

Amino acid conservation in animal glucokinases. Identification of residues implicated in the interaction with the regulatory protein.

Veiga-da-Cunha M, Courtois S, Michel A, Gosselain E, Van Schaftingen E.

J Biol Chem. 1996 Mar 15;271(11):6292-7.

39.

Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene.

De Smet C, Courtois SJ, Faraoni I, Lurquin C, Szikora JP, De Backer O, Boon T.

Immunogenetics. 1995;42(4):282-90.

PMID:
7672823
40.

Characterization of an alternative promoter in the human growth hormone gene.

Courtois SJ, Lafontaine DA, Rousseau GG.

J Biol Chem. 1992 Sep 25;267(27):19736-43.

41.

Sp1 can displace GHF-1 from its distal binding site and stimulate transcription from the growth hormone gene promoter.

Lemaigre FP, Lafontaine DA, Courtois SJ, Durviaux SM, Rousseau GG.

Mol Cell Biol. 1990 Apr;10(4):1811-4.

42.
43.
44.

Analysis of cis- and trans-acting elements in the hormone-sensitive human somatotropin gene promoter.

Lemaigre FP, Courtois SJ, Durviaux SM, Egan CJ, LaFontaine DA, Rousseau GG.

J Steroid Biochem. 1989;34(1-6):79-83.

PMID:
2626054

Supplemental Content

Loading ...
Support Center